Rituximab is active in lymphocyte predominance Hodgkin's disease. Lucas, J. B., Hoppe, R. T., Horwitz, S. M., Breslin, S., Horning, S. J. AMER SOC HEMATOLOGY. 2000: 831A

View details for Web of Science ID 000165256103591